These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2337493)

  • 1. Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.
    Rawles JM; Metcalfe MJ; Jennings K
    Br Heart J; 1990 Apr; 63(4):225-7. PubMed ID: 2337493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of fast heart rate episodes during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Alferness CA; Camm AJ; Malik M
    Heart; 1998 May; 79(5):497-501. PubMed ID: 9659199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of long-term digitalization to prevent rapid ventricular response in patients with paroxysmal atrial fibrillation.
    Galun E; Flugelman MY; Glickson M; Eliakim M
    Chest; 1991 Apr; 99(4):1038-40. PubMed ID: 2009763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid- and long-term similarity of ventricular response to paroxysmal atrial fibrillation: digoxin versus placebo.
    Hnatkova K; Murgatroyd FD; Poloniecki J; Waktare JE; Alferness CA; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1735-40. PubMed ID: 9744436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digoxin for atrial fibrillation: a drug whose time has gone?
    Falk RH; Leavitt JI
    Ann Intern Med; 1991 Apr; 114(7):573-5. PubMed ID: 2001090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1968-71. PubMed ID: 8945079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age and gender influences on rate and duration of paroxysmal atrial fibrillation.
    Hnatkova K; Waktare JE; Murgatroyd FD; Guo X; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2455-8. PubMed ID: 9825366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute ventricular rate control in atrial fibrillation: IV combination of diltiazem and digoxin vs. IV diltiazem alone.
    Wattanasuwan N; Khan IA; Mehta NJ; Arora P; Singh N; Vasavada BC; Sacchi TJ
    Chest; 2001 Feb; 119(2):502-6. PubMed ID: 11171729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inefficacy of "therapeutic" serum levels of digoxin in controlling the ventricular rate in atrial fibrillation.
    Goldman S; Probst P; Selzer A; Cohn K
    Am J Cardiol; 1975 May; 35(5):651-5. PubMed ID: 1124719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of changes in the ventricular rhythm during paroxysmal atrial fibrillation.
    Gallagher MM; Hnatkova K; Murgatroyd FD; Waktare JE; Guo X; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2450-4. PubMed ID: 9825365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.
    Hays JV; Gilman JK; Rubal BJ
    Ann Emerg Med; 1994 Jul; 24(1):61-4. PubMed ID: 8010550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.
    Andersson KE; Johansson BW; Ledermann H; von Schenck H; Thorell JI
    Eur J Clin Invest; 1977 Feb; 7(1):3-6. PubMed ID: 402273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial.
    Falk RH; Knowlton AA; Bernard SA; Gotlieb NE; Battinelli NJ
    Ann Intern Med; 1987 Apr; 106(4):503-6. PubMed ID: 3548521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation.
    Ang EL; Chan WL; Cleland JG; Moore D; Krikler SJ; Alexander ND; Oakley CM
    Br Heart J; 1990 Oct; 64(4):256-60. PubMed ID: 1977430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation.
    Murgatroyd FD; Gibson SM; Baiyan X; O'Nunain S; Poloniecki JD; Ward DE; Malik M; Camm AJ
    Circulation; 1999 Jun; 99(21):2765-70. PubMed ID: 10351970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.